Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

The Cooper Companies, Inc. COO

Healthcare  —  Medical Instruments & Supplies
55.38 0.00 0.00% as of 25 Sep
Market cap
$10.5B
P/E
18.9×
S&P 500 Member Dividend Champion (10y) Revenue Champion (5y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

The Cooper Companies, Inc. (COO) Business Profile

Updated before January 2025

Company Overview

The Cooper Companies, Inc. (COO) is a global medical device company that specializes in providing a diverse range of products and services in the healthcare sector. Founded in 1958 and headquartered in San Ramon, California, COO has grown into a prominent player in the medical device industry. The company operates through two primary business units: CooperVision and CooperSurgical. CooperVision focuses on contact lenses and vision care, while CooperSurgical provides products and services for women’s health and fertility.

The company is led by a team of experienced executives. As of October 2023, Al White serves as the President and Chief Executive Officer (CEO), bringing extensive leadership experience to the organization. Under his guidance, COO has continued to expand its global footprint and strengthen its position in the healthcare market.

Core Business Segments

1. CooperVision

CooperVision is a leading provider of contact lenses and vision care solutions. This segment focuses on addressing a wide range of vision correction needs, including myopia, hyperopia, astigmatism, and presbyopia. Key product categories include:

  • Daily Disposable Lenses: Popular brands like MyDay®, clariti® 1 day, and Biofinity® offer comfort and convenience for users.
  • Toric Lenses: Designed for individuals with astigmatism, these lenses provide precise vision correction.
  • Multifocal Lenses: Products like Biofinity® Multifocal cater to individuals with presbyopia, offering clear vision at multiple distances.
  • Specialty Lenses: CooperVision also offers specialty lenses for conditions like keratoconus and myopia management, including the MiSight® 1 day lens, which is FDA-approved for slowing the progression of myopia in children.

2. CooperSurgical

CooperSurgical focuses on women’s health and fertility, offering a comprehensive portfolio of products and services. Key areas include:

  • Fertility Solutions: Products and services for assisted reproductive technology (ART), including IVF media, embryo transfer catheters, and cryopreservation solutions.
  • Surgical Products: Devices and instruments for gynecological procedures, such as uterine manipulators and laparoscopic instruments.
  • Obstetrics and Neonatal Care: Products designed to support maternal and neonatal health, including fetal monitoring systems and obstetric surgical tools.
  • Genetic Testing Services: CooperSurgical provides genetic testing and screening services to support reproductive health and family planning.

Business Model

The Cooper Companies operates a vertically integrated business model that combines product innovation, manufacturing, and distribution to deliver high-quality medical devices and services. The company generates revenue through the sale of its products to eye care professionals, healthcare providers, and fertility clinics worldwide. Additionally, COO invests heavily in research and development (R&D) to create innovative solutions that address unmet medical needs.

CooperVision’s revenue is driven by the growing demand for contact lenses, particularly in emerging markets where vision correction needs are increasing. CooperSurgical’s revenue comes from its diverse portfolio of women’s health and fertility products, which are supported by strong relationships with healthcare providers and clinics.

Strategic Direction

The Cooper Companies has outlined several strategic priorities to drive future growth:

  • Expansion in Emerging Markets: COO aims to increase its presence in regions like Asia-Pacific and Latin America, where demand for vision care and women’s health products is rising.
  • Sustainability Goals: The company is committed to reducing its environmental footprint by adopting sustainable manufacturing practices and promoting eco-friendly products, such as its clariti® 1 day contact lenses made with sustainable materials.
  • Innovation in Myopia Management: CooperVision is focused on expanding its myopia management portfolio, including the MiSight® 1 day lens, to address the growing prevalence of myopia in children.
  • Growth in Fertility Solutions: CooperSurgical plans to enhance its fertility offerings through acquisitions and partnerships, as well as by investing in advanced technologies for assisted reproduction.
  • Digital Transformation: COO is leveraging digital tools and platforms to improve customer engagement, streamline operations, and enhance the patient experience.

Competitive Landscape

The Cooper Companies operates in highly competitive markets. Key competitors include:

  • Contact Lenses: Johnson & Johnson Vision Care, Alcon, and Bausch + Lomb are major competitors in the contact lens market.
  • Women’s Health and Fertility: Companies like Hologic, Inc., and Thermo Fisher Scientific compete with CooperSurgical in the women’s health and fertility segments.
  • Specialty Lenses: Smaller niche players also compete in the specialty lens market, particularly in myopia management and orthokeratology.

COO differentiates itself through its focus on innovation, high-quality products, and strong customer relationships.

Risk Factors

The Cooper Companies faces several risks that could impact its business:

  • Market Dependence: COO relies heavily on the success of its contact lens and women’s health products. Any decline in demand for these products could affect revenue.
  • Regulatory Challenges: The medical device industry is subject to stringent regulatory requirements, which could delay product launches or result in compliance costs.
  • Supply Chain Disruptions: Global supply chain issues, including shortages of raw materials and transportation delays, could impact COO’s ability to meet customer demand.
  • Currency Fluctuations: As a global company, COO is exposed to currency exchange rate fluctuations, which could affect financial performance.
  • Competition: Intense competition in the contact lens and medical device markets could pressure pricing and margins.

Recent Developments

  • Myopia Management Expansion: In 2023, CooperVision expanded its myopia management portfolio with the launch of new products and partnerships aimed at addressing the global myopia epidemic.
  • Sustainability Initiatives: COO announced new sustainability goals, including reducing carbon emissions and increasing the use of renewable energy in its manufacturing facilities.
  • Acquisitions: CooperSurgical completed the acquisition of several fertility-focused companies to strengthen its position in the assisted reproduction market.
  • Digital Tools: COO introduced new digital platforms to enhance customer engagement and streamline operations.

Investment Considerations

Strengths:

  • Strong market position in contact lenses and women’s health.
  • Diversified product portfolio with a focus on innovation.
  • Growing presence in emerging markets.
  • Commitment to sustainability and corporate responsibility.

Risks:

  • Dependence on key product categories.
  • Exposure to regulatory and compliance risks.
  • Vulnerability to supply chain disruptions.
  • Intense competition in core markets.

Conclusion

The Cooper Companies, Inc. is a leading player in the medical device industry, with a strong focus on contact lenses and women’s health. The company’s commitment to innovation, sustainability, and global expansion positions it well for future growth. However, investors should consider potential risks, including market dependence and regulatory challenges, when evaluating COO as an investment opportunity. Overall, COO’s diversified portfolio and strategic initiatives make it a compelling choice for long-term growth in the healthcare sector.